Colchicine, a cheap and widely used gout drug, may help prevent heart attacks and strokes in people with cardiovascular ...

The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...

Alkermes' experimental drug significantly improved wakefulness and reduced excessive daytime sleepiness in patients with a rare sleep disorder in a mid-stage study, it said on Wednesday. Shares of the ...

Patients with severe hypertriglyceridemia have an increased risk of acute pancreatitis. The efficacy and safety of olezarsen, ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Join Wish of a Lifetime from AARP in celebrating veterans with ...

Over the last decade, clinics have popped up across Southern California and beyond advertising something called magnetic ...

Robust evidence regarding adjunct treatments for depression already exists for physical ... Disruptions in interoception are ...

Abstract: Misbehavior detection systems (MDS) play a crucial role in vehicular ad hoc networks (VANETs) to guarantee their secure operation. Most recent studies focus on applying machine learning ...

WEST VIRGINIA (WVNS) – An estimated 300,000 women are diagnosed with invasive breast cancer each year, according to the American Cancer Society. A West Virginia survivor has called on lawmakers to ...

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) are trading lower Friday following approval of one of its treatments from the U.S.’s Food and Drug Administration. SNDX shares are retreating from ...

Submitted data were not enough to support the effectiveness of SYD-101 in children with myopia, according to the FDA. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) ...

Chess’s international governing body is considering disciplinary action against a Russian former world champion who persistently leveled unproven cheating allegations at Daniel Naroditsky in the year ...